Heparin Induced Thrombocytopenia in COVID-19 patients- a Diagnostic Dilemma

Daviet F, Guervilly C, Baldesi O, Bernard-Guervilly F, Pilarczyk E, Genin A et al (2020) Heparin-Induced Thrombocytopenia in Severe COVID-19. Circulation 142:1875–1877

Nazy I, Jevtic SD, Moore JC, Huynh A, Smith JW, Kelton JG et al (2021) Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia. J Thromb Haemost 19:1342–1347

Kotwal J, Chaudhary S, Manoj MG, Hasnain S, Nair V, Luthra M (2014) Heparin: Induced thrombocytopenia: Incidence and laboratory approach to diagnosis in Indians. Indian J Pathol Microbiol 57:31–38

Adam Cuker GM, Arepally, Beng H, Chong DB, Cines A, Greinacher Y, Gruel et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv 2:3360–3392

Lingamaneni P, Gonakoti S, Moturi K, Vohra I, Zia M (2020) Heparin-Induced Thrombocytopenia in COVID-19. J Investig Med High Impact Case Rep 8:2324709620944091

Parzy G, Daviet F, Persico N, Rambaud R, Scemama U, Adda M et al (2020) Prevalence and risk factors for thrombotic complications following venovenous extracorporeal membrane oxygenation: a CT scan study. Crit Care Med 48:192–199